Murugesan S - Search Results

1

Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.

Srinivasarao S, Nandikolla A, Suresh A, Ewa AK, Głogowska A, Ghosh B, Kumar BK, Murugesan S, Pulya S, Aggarwal H, Sekhar KVGC. Srinivasarao S, et al. Among authors: murugesan s. Bioorg Chem. 2020 Jul;100:103955. doi: 10.1016/j.bioorg.2020.103955. Epub 2020 May 20. Bioorg Chem. 2020. PMID: 32464405

2

Design, synthesis of new β-carboline derivatives and their selective anti-HIV-2 activity.

Ashok P, Chander S, Balzarini J, Pannecouque C, Murugesan S. Ashok P, et al. Among authors: murugesan s. Bioorg Med Chem Lett. 2015 Mar 15;25(6):1232-5. doi: 10.1016/j.bmcl.2015.01.058. Epub 2015 Jan 30. Bioorg Med Chem Lett. 2015. PMID: 25682562

3

Synthesis, evaluation and molecular docking studies of amino acid derived N-glycoconjugates as antibacterial agents.

Baig N, Singh RP, Chander S, Jha PN, Murugesan S, Sah AK. Baig N, et al. Among authors: murugesan s. Bioorg Chem. 2015 Dec;63:110-5. doi: 10.1016/j.bioorg.2015.10.002. Epub 2015 Oct 9. Bioorg Chem. 2015. PMID: 26476390

4

Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.

Penta A, Franzblau S, Wan B, Murugesan S. Penta A, et al. Among authors: murugesan s. Eur J Med Chem. 2015 Nov 13;105:238-44. doi: 10.1016/j.ejmech.2015.10.024. Epub 2015 Oct 23. Eur J Med Chem. 2015. PMID: 26498570

5

Design, synthesis and in-vitro evaluation of novel tetrahydroquinoline carbamates as HIV-1 RT inhibitor and their antifungal activity.

Chander S, Ashok P, Zheng YT, Wang P, Raja KS, Taneja A, Murugesan S. Chander S, et al. Among authors: murugesan s. Bioorg Chem. 2016 Feb;64:66-73. doi: 10.1016/j.bioorg.2015.12.005. Epub 2015 Dec 17. Bioorg Chem. 2016. PMID: 26717022

6

Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents.

Chander S, Ashok P, Cappoen D, Cos P, Murugesan S. Chander S, et al. Among authors: murugesan s. Chem Biol Drug Des. 2016 Oct;88(4):585-91. doi: 10.1111/cbdd.12788. Epub 2016 Jun 24. Chem Biol Drug Des. 2016. PMID: 27203404

7

Rational design, synthesis, anti-HIV-1 RT and antimicrobial activity of novel 3-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-1-(piperazin-1-yl)propan-1-one derivatives.

Chander S, Wang P, Ashok P, Yang LM, Zheng YT, Murugesan S. Chander S, et al. Among authors: murugesan s. Bioorg Chem. 2016 Aug;67:75-83. doi: 10.1016/j.bioorg.2016.05.009. Epub 2016 Jun 1. Bioorg Chem. 2016. PMID: 27288643

8

Design, synthesis and α-amylase inhibitory activity of novel chromone derivatives.

Valentina P, Ilango K, Chander S, Murugesan S. Valentina P, et al. Among authors: murugesan s. Bioorg Chem. 2017 Oct;74:158-165. doi: 10.1016/j.bioorg.2017.07.018. Epub 2017 Aug 1. Bioorg Chem. 2017. PMID: 28802166

9

Rational modification of a lead molecule: Improving the antifungal activity of indole - triazole - amino acid conjugates.

Mishra S, Kaur M, Chander S, Murugesan S, Nim L, Arora DS, Singh P. Mishra S, et al. Among authors: murugesan s. Eur J Med Chem. 2018 Jul 15;155:658-669. doi: 10.1016/j.ejmech.2018.06.039. Epub 2018 Jun 18. Eur J Med Chem. 2018. PMID: 29936353

10

Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases.

Kumar BK, Faheem, Sekhar KVGC, Ojha R, Prajapati VK, Pai A, Murugesan S. Kumar BK, et al. Among authors: murugesan s. J Biomol Struct Dyn. 2022 Feb;40(3):1363-1386. doi: 10.1080/07391102.2020.1824814. Epub 2020 Sep 28. J Biomol Struct Dyn. 2022. PMID: 32981461 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

405 results

Search Page

Filters